Placebo-controlled trial of vitamin K supplementation on bone mineral density in primary biliary cirrhosis (PBC).

被引：0
|
作者：
Gleeson, D
Hodges, S
Rigney, E
Blumsohn, A
Hannon, R
Peel, NFA
Eastell, R
机构：
[1] Sheffield Teaching Hosp, Sheffield, S Yorkshire, England
[2] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England
来源：
HEPATOLOGY | 2003年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
740
引用
收藏
页码：516A / 516A
页数：1
相关论文
共 50 条
  • [1] Alendronate improves bone mineral density in primary biliary cirrhosis: A randomized placebo-controlled trial
    Zein, CO
    Jorgensen, RA
    Clarke, B
    Wenger, DE
    Keach, JC
    Angulo, P
    Lindor, KD
    HEPATOLOGY, 2005, 42 (04) : 762 - 771
  • [2] Alendronate improves bone mineral density in patients with PBC: Randomized placebo-controlled trial
    Zein, CO
    Jorgensen, RA
    Clarke, B
    Lindor, KD
    GASTROENTEROLOGY, 2004, 126 (04) : A671 - A671
  • [3] A placebo controlled randomised crossover trial of oral antioxidant supplementation for fatigue in primary biliary cirrhosis (PBC)
    Prince, MI
    Mitchison, HC
    Ashleigh, D
    Burke, D
    Edwards, M
    Bramble, MG
    James, OFW
    Jones, DEJ
    GUT, 2003, 52 (05)
  • [4] A placebo controlled randomised crossover trial of oral antioxidant supplementation for fatigue in primary biliary cirrhosis (PBC).
    Prince, M
    Mitchison, HC
    Ashley, D
    Burke, DA
    Edwards, M
    Bramble, MG
    James, OF
    Jones, DE
    HEPATOLOGY, 2002, 36 (04) : 417A - 417A
  • [5] Vitamin K supplementation and bone mineral density in dialysis: results of the double-blind, randomised, placebo-controlled RenaKvit trial
    Levy-Schousboe, Karin
    Marckmann, Peter
    Frimodt-Moller, Marie
    Peters, Christian D.
    Kjaergaard, Krista D.
    Jensen, Jens D.
    Strandhave, Charlotte
    Sandstrom, Hanne
    Hitz, Mette F.
    Langdahl, Bente
    Vestergaard, Peter
    Brasen, Claus L.
    Schmedes, Anne
    Madsen, Jonna S.
    Jorgensen, Niklas R.
    Frokjaer, Jens B.
    Frandsen, Niels E.
    Petersen, Inge
    Hansen, Ditte
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (10) : 2131 - 2142
  • [6] Bone mineral density in primary biliary cirrhosis (PBC): The effect of histological stage
    Rautiainen, HM
    Karvonen, AL
    Pikkarainen, P
    Nurmi, H
    Karkkainen, P
    Farkkila, MA
    GASTROENTEROLOGY, 2001, 120 (05) : A576 - A576
  • [7] DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF PREDNISOLONE TREATMENT IN PRIMARY BILIARY-CIRRHOSIS (PBC) - A 3 YEAR UPDATE
    MITCHISON, HC
    BASSENDINE, MF
    WATSON, AJ
    RECORD, CO
    JAMES, OFW
    JOURNAL OF HEPATOLOGY, 1989, 9 (01) : P4 - P4
  • [8] Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomized, Placebo-Controlled Trial
    Wong, Rachel H. X.
    Thaung-Zaw, Jay Jay
    Xian, Cory J.
    Howe, Peter R. C.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 (11) : 2121 - 2131
  • [9] Vitamin D receptor (VDR) haplogroups as independent genetic predictors of decreased bone mineral density (BMD) in primary biliary cirrhosis (PBC).
    Heathcote, EJ
    Cole, DEC
    Peltekova, V
    CauchDudek, K
    Evrovski, J
    Harewood, L
    Springer, J
    Krishnan, S
    Rubin, L
    GASTROENTEROLOGY, 1997, 112 (04) : A1280 - A1280
  • [10] A PLACEBO-CONTROLLED TRIAL OF PRIMARY BILIARY-CIRRHOSIS TREATMENT WITH COLCHICINE AND URSODEOXYCHOLIC ACID
    VUORISTO, M
    FARKKILA, M
    KARVONEN, AL
    LEINO, R
    LEHTOLA, J
    MAKINEN, J
    MATTILA, J
    FRIMAN, C
    SEPPALA, G
    TUOMINEN, J
    MIETTINEN, TA
    GASTROENTEROLOGY, 1995, 108 (05) : 1470 - 1478
12345